Pfizer And FDA Delay Application For Covid-19 Vaccine To Children Under 5.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      PFIZER Inc.; BIONTECH SE; UNITED States. Food & Drug Administration
    • Abstract:
      Pfizer and BioNTech said they are waiting for data on the efficacy of a third dose of the vaccine for children ages 6 months to 4 years. [ABSTRACT FROM AUTHOR]
    • Abstract:
      Copyright of Forbes.com is the property of Forbes Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)